Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Structure-Guided Design of a Bioactive Covalent Small Molecule Targeting a Riboswitch
Chungen Li, Xueyi Yang, Kyle A Dickerson, et al.
Journal of Medicinal Chemistry
|
February 3, 2023
Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against <i>Mycobacterium tuberculosis</i>
Chungen Li, Xirong Tian, Zongkai Huang, et al.
Journal of Medicinal Chemistry
|
December 14, 2021
Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment
Chungen Li, Xiaowei Yang, Yuan Luo, et al.
Journal of Medicinal Chemistry
|
August 22, 2023
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve
Chungen Li, Yuanyuan Qiao, Xia Jiang, et al.
Journal of Medicinal Chemistry
|
April 30, 2024
Discovery of LLC0424 as a Potent and Selective <i>in Vivo</i> NSD2 PROTAC Degrader
Lianchao Liu, Abhijit Parolia, Yihan Liu, et al.
European Journal of Medicinal Chemistry
|
September 17, 2022
Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold
Chungen Li, Yue Zhou, Jing Xu, et al.
Cell Reports. Medicine
|
March 25, 2026
Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors
Yizhi Cao, Caleb Cheng, Yitong Yin, et al.
Journal of Medicinal Chemistry
|
October 23, 2023
Discovery and Optimization of Novel <i>h</i>DHODH Inhibitors for the Treatment of Inflammatory Bowel Disease
Xia Zhou, Kun Gou, Jing Xu, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
Caleb Cheng, Jing Hu, Rahul Mannan, et al.
Nature
|
April 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
Caleb Cheng, Jing Hu, Rahul Mannan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Biorxiv : the Preprint Server for Biology
|
August 6, 2025
Structure-Guided Design of a Bioactive Covalent Small Molecule Targeting a Riboswitch
Chungen Li, Xueyi Yang, Kyle A Dickerson, et al.
Journal of Medicinal Chemistry
|
February 3, 2023
Structure-Activity Relationship of Novel Pyrimidine Derivatives with Potent Inhibitory Activities against <i>Mycobacterium tuberculosis</i>
Chungen Li, Xirong Tian, Zongkai Huang, et al.
Journal of Medicinal Chemistry
|
December 14, 2021
Design, Synthesis, and Biological Evaluation of a Novel Series of Teriflunomide Derivatives as Potent Human Dihydroorotate Dehydrogenase Inhibitors for Malignancy Treatment
Chungen Li, Xiaowei Yang, Yuan Luo, et al.
Journal of Medicinal Chemistry
|
August 22, 2023
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyve
Chungen Li, Yuanyuan Qiao, Xia Jiang, et al.
Journal of Medicinal Chemistry
|
April 30, 2024
Discovery of LLC0424 as a Potent and Selective <i>in Vivo</i> NSD2 PROTAC Degrader
Lianchao Liu, Abhijit Parolia, Yihan Liu, et al.
European Journal of Medicinal Chemistry
|
September 17, 2022
Discovery of potent human dihydroorotate dehydrogenase inhibitors based on a benzophenone scaffold
Chungen Li, Yue Zhou, Jing Xu, et al.
Cell Reports. Medicine
|
March 25, 2026
Targeting the ferritinophagy-lysosome axis as a therapeutic vulnerability in gastroenteropancreatic neuroendocrine tumors
Yizhi Cao, Caleb Cheng, Yitong Yin, et al.
Journal of Medicinal Chemistry
|
October 23, 2023
Discovery and Optimization of Novel <i>h</i>DHODH Inhibitors for the Treatment of Inflammatory Bowel Disease
Xia Zhou, Kun Gou, Jing Xu, et al.
Biorxiv : the Preprint Server for Biology
|
April 2, 2024
Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer
Caleb Cheng, Jing Hu, Rahul Mannan, et al.
Nature
|
April 24, 2025
Targeting PIKfyve-driven lipid metabolism in pancreatic cancer
Caleb Cheng, Jing Hu, Rahul Mannan, et al.
Page
of 3